Ratio 125%: reformulate [RSABE / ABEL]

posted by drsinghs – India, 2012-05-10 07:49 (5145 d 01:56 ago) – Posting: # 8549
Views: 9,889

❝ If your observed T/R ratio is 125 %, your chances to get a 90 % CI within 80.00 - 125.00 % in the next study, even with a replicate design, are close to nil.


Thanks ohlbe,

Can I once again request you to please comment on my other query as below?

This is regarding a Modified release HVDP. If I check same batch of test and reference by both 2 way crossover and replicate design, what kind of differences in results can I expect? Basically I want to understand the impact of change in study design on BE results.

Thanks & regards,
drsinghs

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
205 visitors (0 registered, 205 guests [including 17 identified bots]).
Forum time: 09:46 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5